Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Cash Flow-to-Debt Ratio
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥24.79 Million could theoretically repay 0% of its total liabilities (CN¥166.97 Million) in one year. Check 301206 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Sanyuan Biotechnology Co.Ltd. Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Shandong Sanyuan Biotechnology Co.Ltd. across 12 annual periods. Also explore Shandong Sanyuan Biotechnology Co.Ltd. total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
Year-by-year debt coverage analysis for Shandong Sanyuan Biotechnology Co.Ltd.. For market capitalisation and broader financial context, see Shandong Sanyuan Biotechnology Co.Ltd. market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.04x | CN¥-13.65 Million | CN¥314.04 Million | ▼ -120.7% |
| 2023 | 0.21x | CN¥57.31 Million | CN¥272.40 Million | ▼ -37.8% |
| 2022 | 0.34x | CN¥84.26 Million | CN¥249.14 Million | ▼ -69.0% |
| 2021 | 1.09x | CN¥642.08 Million | CN¥588.83 Million | ▲ +36.2% |
| 2020 | 0.80x | CN¥217.37 Million | CN¥271.48 Million | ▼ -5.8% |
| 2019 | 0.85x | CN¥149.21 Million | CN¥175.59 Million | ▲ +30.0% |
| 2018 | 0.65x | CN¥65.46 Million | CN¥100.12 Million | ▲ +110.9% |
| 2017 | 0.31x | CN¥20.25 Million | CN¥65.31 Million | ▼ -45.4% |
| 2016 | 0.57x | CN¥22.96 Million | CN¥40.44 Million | ▲ +47.3% |
| 2015 | 0.39x | CN¥9.50 Million | CN¥24.64 Million | ▲ +270.0% |
| 2014 | 0.10x | CN¥3.20 Million | CN¥30.68 Million | ▼ -48.8% |
| 2013 | 0.20x | CN¥3.89 Million | CN¥19.10 Million | — |